| 428. | Hawro, T., Prybyłowicz, K., Spindler, M., Hawro, M., Steć, M., Altrichter, S., Weller, K., Magerl, M., Reidel, U., Alarbeed, E., Alraboni, O., Maurer, M.+, and Metz, M.: The characteristics and impact of pruritus in in adult dermatologic patients: a prospective, cross-sectional study. J. Am. Acad. Dermatol. 2021: 84; 691-700. IF: 15.49 |
o.428
| 164. | Kühn, H., Kolkhir, P., Babina, M., Düll, M., Frischbutter, S., Fok, J. S., Jiao, Q., Metz, M., Scheffel, J., Wolf, K., Kremer, A. E., and Maurer, M.+: Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergies. J. Allergy Clin. Immunol. 2021: 147; 456-469. IF: 14.29 |
r.164
Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergies Read More »
| 406. | Lehmann, S., Deuring, E., Weller, K., Scheffel, J., Metz, M., Maurer, M., and Hawro, T.+: Flare size but not intensity reflects histamine-induced itch. Skin Pharmacol. Phys. 2020: 33; 244-252. IF: 3.48 |
o.406
Flare size but not intensity reflects histamine-induced itch Read More »
| 248 | Ständer, S.+, Metz, M., Ramos, M. H., Maurer, M. Schoepke, N., Tsianakas, A., Zeidler, C., and Luger, T. A.: Anti-pruritic effect of sertaconazole 2% cream in atopic dermatitis subjects: a prospective, randomized, double-blind, vehicle-controlled, multi-centre clinical trial of efficacy, safety and local tolerability. Acta Derm. Venereol. 2016: 96; 792-796. IF: 3.65 |
| 259 | Hawro, T., Lehmann, S., Altrichter, S., Fluhr, J. W., Zuberbier, T., Church, M. K., Maurer, M.+ and Metz, M.: Skin provocation tests may help to diagnose atopic dermatitis. Allergy 2016: 71; 1745-1752. IF: 7.36 |
Skin provocation tests may help to diagnose atopic dermatitis Read More »
| 211 | Casale, T. B., Bernstein, J. A., Maurer, M. Saini, S. S., Trzaskoma, B., Chen, H., Grattan, C., Gimenèz-Arnau, A., Kaplan, A. P., and Rosén, K.+: Similar efficacy with Omalizumab in chronic idiopathic/spontaneous urticaria despite different background therapy. J. Allergy Clin. Immunol. Pract. 2015: 3; 743-750. IF: 5.42 |
| 291 | Hawro, T., Ohanyan, T., Schoepke, N., Metz, M., Peveling-Oberhag, A., Staubach, P., Maurer, M. and Weller, K.+: Comparison and interpretability of the available urticaria activity scores. Allergy 2018: 73; 251-255. IF: 6.77 |
Comparison and interpretability of the available urticaria activity scores Read More »
| 201 | Hawro, T., Saluja, R., Weller, K., Altrichter, S., Metz, M., and Maurer, M.+: Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge. Allergy 2014: 69; 113-117. IF: 6.03 |
o.201
| 19. | Maurer, M. and Staubach, P.: Praktische Tipps für die Betreuung von Patienten mit Urtikaria. Allergologie 2007: 6; 211-215. IF: 0.16 |
Praktische Tipps für die Betreuung von Patienten mit Urtikaria Read More »
| 195 | Hawro, T., Fluhr, J. W., Mengeaud, V., Redoulès, D., Church, M. K., Maurer, M. and Metz, M.+: Polidocanol inhibits cowhage – but not histamine-induced itch in humans. Exp. Dermatol. 2014: 23; 922-941. IF: 3.76 |
Polidocanol inhibits cowhage – but not histamine-induced itch in humans Read More »